peoplePerson
Aaron D. Schimmer
Leukaemia researcher who found that AML stem cells depend on mitochondrial proteases and metabolism.
Identified mitochondrial dependencies (ClpP, oxidative phosphorylation) in AML and led repurposing trials such as tigecycline; directs research at Princess Margaret.
Role
Research Director, Princess Margaret Cancer Centre; Senior Scientist
Institution
Specialisms
AMLMitochondrial metabolismDrug repurposing
Profiles
| Title | Journal | Year |
|---|---|---|
| Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia | Cancer Cell | 2011 |